Anti-a bioclone 15X10ML
Ended Awarded
- Contract number
- SPE2D623F9YQ7
- Awardee
-
Ortho-Clinical Diagnostics, Inc. UEI JG5JF2JQJ121
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $916
Award facts
- Contract value 100% obligated
- $916.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Raritan, NJ 08869, USA
Award details come from SAM.gov/FPDS.
About this award
Ortho-Clinical Diagnostics Inc. was awarded a $916 fixed-price delivery order with economic price adjustment against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical. The delivery order (Contract #4561974865) is for 15 boxes containing 10 milliliters each of an unspecified anti-A biologic product. Performance will occur in Raritan, New Jersey with all work required to be completed by September 19, 2023. No set-aside provisions were applied to this award to supply medical products in support of the Defense Logistics Agency Troop Support's mission to provision the United States military worldwide.
Quick answers
Who was awarded contract SPE2D623F9YQ7?
SPE2D623F9YQ7 was awarded to Ortho-Clinical Diagnostics, Inc. by Medical Supply Chain (Troop Support) on August 28, 2023.
How much is contract SPE2D623F9YQ7 worth?
The government has obligated $916 on SPE2D623F9YQ7.
Is contract SPE2D623F9YQ7 an order under another contract?
Yes. SPE2D623F9YQ7 is a delivery order under SPE2DE21D0007, an indefinite delivery contract.
Was contract SPE2D623F9YQ7 competed?
The extent of competition for SPE2D623F9YQ7 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award